Tri-Legest Fe28 Day (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Tri-Legest Fe drug offered from Teva Pharmaceuticals USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Norethindrone Acetate and Ethinyl Estradiol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2007-10-26 |
END MARKETING DATE: | 0000-00-00 |
Tri-Legest Fe 28 Day HUMAN PRESCRIPTION DRUG Details:
Item Description | Tri-Legest Fe 28 Day from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2007-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0555-9032_51ae94a5-069a-47fd-a964-4a9eee3c12a2 |
PRODUCT NDC: | 0555-9032 |
APPLICATION NUMBER: | ANDA076105 |